Update on Biomarin’s Pompe Clinical Program—January 2015

BioMarin are pausing further recruitment for their BMN-701 clinical trial and have provided this programme update: January 2015 BioMarin is pleased to update the Pompe patient community on the progress made in our programme to develop a treatment for people living...

2014 Helen Walker Research Grant Awarded

The fifth annual AMDA Research Grant (the 2014 Helen Walker Research Grant) was awarded to Dr. Giancarlo Parenti with the Federico II University in Naples, Italy for his Project: “Analysis of Circulating and Tissue Specific microRNAs in Pompe Disease.” Despite...
Design And Performance Of Clinical Trials: An Overview

Design And Performance Of Clinical Trials: An Overview

Webinar Details Title: Design and Performance of Clinical Trials: An Overview Date: Monday, October 20, 2014 Speaker:Anne Zajicek, MD, PharmD, FAAP, Chief, Obstetric and Pediatric, Pharmacology and Therapeutics Branch, National Institute of Child Health and Human...

United States Pompe Community Update from Genzyme

Genzyme would like to share with you an important update regarding the recent United States (U.S.) Food and Drug Administration’s (FDA) approval of an expanded label for Lumizyme® (alglucosidase alfa) manufactured at the 4000L scale and its impact on Myozyme®...